Following People With COPD to Study Flare-Ups Over Time
Follows adults with chronic obstructive pulmonary disease to study their flare-ups and health.
Plain-language title generated from the registry record
Registry title: The London COPD Exacerbation Cohort
Key facts
- Where
- London, United KingdomSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 100 years old?
Source: NCT02755974, who can take part
Where in United Kingdom
- National Heart and Lung Institute, Imperial CollegeLondon, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Imperial College London
- Trial code
- NCT02755974
- Record updated
- 21 June 2022
- Original description
The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.Read full original descriptionShow less
Relationship Between Patient Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.
The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.
Inclusion: Forced Expiratory Volume in 1 sec (FEV1)/Forced Vital Capacity (FVC) ratio of <0.70; Able and willing to give informed and written consent.
Exclusion: Long term steroid therapy; Patients with a history of asthma, bronchiectasis, carcinoma of the bronchus, or other significant respiratory disease were excluded; Patients on Immunosuppressive medications or with active cancer; Age <40 years at recruitment.